Viral reactivation and pseudotype production in an in vitro superinfection system with two different strains of HIV-1

Archives of Virology

Volumn 151, Issue 4, 2006, Pages 651-662

  Fernandez Larrosa P N ^a   Ceballos, A ^a   Andreani, G ^a   Marquina, S ^a   Martinez Peralta L ^a   Rabinovich, R D ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; CELL LINE; COCULTURE; CYTOPATHOGENIC EFFECT; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PHYSIOLOGY; SERODIAGNOSIS; SUPERINFECTION; TIME; VIROLOGY; VIRUS ACTIVATION; VIRUS GENOME;

CELL LINE; COCULTURE TECHNIQUES; CYTOPATHOGENIC EFFECT, VIRAL; GENOME, VIRAL; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; NEUTRALIZATION TESTS; SUPERINFECTION; TIME FACTORS; VIRUS ACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33645019006     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-005-0670-2     Document Type: Article

References (35)

1. TM Allen M Altfeld 2003 HIV-1 superinfection. J Allergy Clin Immunol 112 829 835
2. JT Blackard DE Cohen KH Mayer 2002 Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clin Infect Dis 34 1108 1114
3. CG Bridges TM Brennan DL Taylor M [tmp] McPherson AS Tyms 1994 The prevention of cell adhesion and the cell-to-cell spread of HIV-1 in vitro by the alpha-glucosidase 1 inhibitor, 6-O-butanoyl castanospermine (MDL 28574). Antiviral Res 25 169 175
4. JM Carr H Hocking P Li CJ Burrell 1999 Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology 265 319 329
5. G Fang B Weiser C Kuiken SM Philpott S Rowland-Jones F Plummer J Kimani B Shi R Kaul J Bwayo O Anzala H Burger 2004 Recombination following superinfection by HIV-1. AIDS 8 2 153 159
6. JF Fortin R Cantin G Lamontagne M Tremblay 1997 Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J Virol 71 3588 3596
7. D Gallo JL Diggs GR Shell PJ Dailey MN Hoffman JL Riggs 1986 Comparison of detection of antibody to the acquired immune deficiency syndrome virus by enzyme immunoassay, immunofluorescence, and Western blot methods. J Clin Microbiol 23 1049 1051
8. GS Gottlieb DC Nickle MA Jensen KG Wong J Grobler F Li S Liu C Rademeyer GH Learn SS Abdool Karim C Williamson L Corey JB Margolick JI Mullins 2004 Dual HIV-1 infection associated with rapid disease progression. Lancet 363 619 622
9. J Grobler CM Gray C Rademeyer C Seoighe G Ramjee SA Karim L Morris C Williamson 2004 Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. Infect Dis 190 7 1355 1359 (Epub 2004 Aug 25)
10. KL Gross TC Porco RM Grant 2004 HIV-1 superinfection and viral diversity. AIDS 18 11 1513 1520
11. Z Gu Q Gao EA Faust MA Wainberg 1995 Possible involvement of cell fusion and viral recombination in generation of human immunodeficiency virus variants that display dual resistance to AZT and 3TC. J Gen Virol 76 2601 2605
12. S Jost MC Bernard L Kaiser S Yerly B Hirschel A Samri B Autran LE Goh L Perrin 2002 A patient with HIV-1 superinfection. N Engl J Med 347 731 736
13. JH Kim JD Mosca MT Vahey RJ [tmp] McLinden DS Burke RR Redfield 1993 Consequences of human immunodeficiency virus type 1 superinfection of chronically infected cells. AIDS Res Hum Retrovir 9 9 875 882
14. M Le Guern JA Levy 1992 Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range. Proc Natl Acad Sci USA 89 363 367
15. T Leitner G Korovina S Marquina T Smolskaya J Albert 1996 Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variant. AIDS Res Hum Retrovir 12 1595 1603
16. L Li JM Olvera KE Yoder RS Mitchell SL Butler M Lieber SL Martin FD Bushman 2001 Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J 20 3272 3281
17. CP Locher DJ Blackbourn SW Barnett KK Murthy EK Cobb S Rouse G Greco G Reyes-Teran KM Brasky KD Carey JA Levy 1997 Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response. J Infect Dis 176 948 959
18. O Manigart V Courgnaud O Sanou D Valea N Nagot N Meda E Delaporte M Peeters P Van de Perre 2004 HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso as assessed by an autologous heteroduplex mobility procedure. AIDS 18 12 1645 1651
19. S Marquina O Libonatti A Ceballos M Gomez Carrillo L Martinez Peralta RD Rabinovich 1997 Different integrated and unintegrated HIV-1 DNA after superinfection and cell to cell transmission. Acta Physiol Pharmacol Ther Latinoam 47 245 250
20. FE [tmp] McCutchan 2000 Understanding the genetic diversity of HIV-1. AIDS 14 31 44
21. M Moriuchi H Moriuchi 2002 In vitro reactivation of HIV-1 by stimulation with herpes simplex virus infection. Sex Transm Dis 29 308 309
22. G Pantaleo JF Demarest M Vaccarezza C Graziosi GP Bansal S Koenig AS Fauci 1995 Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission. Eur J Immunol 25 226 231
23. H Petry U Dittmer C Stahl-Hennig C Coulibaly B Makoschey D Fuchs H Wachter T Tolle C Morys-Wortmann FJ Kaup 1995 Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. J Virol 69 1564 1574
24. JC Plantier V Lemee I Dorval M Gueudin J Braun P Hutin A Ruffault F Simon 2004 HIV-1 group M superinfection in an HIV-1 group O-infected patient. AIDS 18 18 2444 2446
25. A Ramos DJ Hu L Nguyen KO Phan S Vanichseni N Promadej K Choopanya M Callahan NL Young J [tmp] McNicholl TD Mastro TM Folks S Subbarao 2002 Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 76 7444 7452
26. T Schacker 2001 The role of HSV in the transmission and progression of HIV. Herpes 8 46 49
27. N Sipsas PP Sfikakis P Sfikakis H Choremi T Kordossis 1994 Serum concentrations of soluble intercellular adhesion molecule-1 and progress towards disease in patients infected with HIV. J Infect 29 271 282
28. DM Smith JK Wong GK Hightower CC Ignacio KK Koelsch ES Daar DD Richman SJ Little 2004 Incidence of HIV superinfection following primary infection. JAMA 292 10 1177 1178
29. JE Taylor BT Korber 2005 HIV-1 intra-subtype superinfection rates: estimates using a structured coalescent with recombination. Infect Genet Evol 5 1 85 95
30. HM Temin E Keshet SK Weller 1980 Correlation of transient accumulation of linear unintegrated viral ADN and transient cell killing by avian leukosis and reticuloendotheliosis viruses. Cold Spring Harbor Symp Quant Biol 44 773 778
31. R Tsui BL Herring JD Barbour RM Grant P Bacchetti A Kral BR Edlin EL Delwart 2004 Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure. J Virol 78 94 103
32. DJ Volsky M Simm M Shahabuddin G Li W Chao MJ Potash 1996 Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4. J Virol 70 3823 3833
33. X Wei SK Ghosh ME Taylor VA Johnson EA Emini P Deutsch JD Lifson S Bonhoeffer MA Nowak BH Hahn 1995 Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373 117 122
34. OO Yang ES Daar BD Jamieson A Balamurugan DM Smith JA Pitt CJ Petropoulos DD Richman SJ Little AJ Brown 2005 Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol 79 2 860 868
35. S Yerly S Jost M Monnat A Telenti M Cavassini JP Chave L Kaiser P Burgisser L Perrin Swiss HIV Cohort Study 2004 HIV-1 co/super-infection in intravenous drug users. AIDS 18 10 1413 1421